HER-2 overexpression differentially alters transforming growth factor-β responses in luminal versus mesenchymal human breast cancer cells
2005

HER-2 Overexpression Affects TGF-β Responses in Breast Cancer Cells

publication 15 minutes Evidence: moderate

Author Information

Author(s): Cindy A. Wilson, Elaina E. Cajulis, Jennifer L. Green, Taylor M. Olsen, Young Ah Chung, Michael A. Damore, Judy Dering, Frank J. Calzone, Dennis J. Slamon

Primary Institution: Department of Medicine, David Geffen School of Medicine at UCLA

Hypothesis

Does HER-2 overexpression alter the growth inhibitory effects of TGF-β in breast cancer cells?

Conclusion

HER-2 overexpression promotes breast cancer cell growth by making them resistant to TGF-β's growth inhibitory effects.

Supporting Evidence

  • HER-2 overexpression diminishes TGF-β's ability to inhibit cell growth in MCF-7 cells.
  • In MDA-MB-231 cells, HER-2 overexpression enhances TGF-β's pro-invasive effects.
  • TGF-β signaling is altered in breast cancer cells with high HER-2 expression.

Takeaway

When breast cancer cells have too much HER-2, they don't listen to a signal that usually tells them to stop growing, which can make the cancer worse.

Methodology

Cell proliferation assays, microarray analysis, and various biochemical assays were used to assess the effects of TGF-β on breast cancer cells with different levels of HER-2 expression.

Potential Biases

Potential bias due to the use of engineered cell lines which may not fully mimic in vivo conditions.

Limitations

The study primarily focuses on specific breast cancer cell lines and may not fully represent the complexity of breast cancer in patients.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1343

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication